1Schrier RW, Wang W. Acute renal failure and sepsis[J]. N Engl J Med, 2004,351:159-169.
2Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008[J]. Intensive Care Med, 2008,34:17-60.
3Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit[J]. N Engl J Med, 2004,350:2247-2256.
4Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients[J]. N Engl J Med, 2001,345:1359-1367.
5Vincent JL, Bernard GR, Beale R, et al. Drotrecogin alfa (activated) treatment in severe sepsis from the global open label trial ENHANCE: Further evidence for survival and safety and implications for early treatment[J]. Crit Care Med, 2005,33:2266-2277.
6Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial[J]. Lancet, 2000,356:26-30.
8Tumlin J, Wall R, Williams W, et al. Efficacy and safety of renal tubule cell therapy for acute renal failure[J]. J Am Soc Nephrol, 2008, 19:1034-1040.
二级参考文献29
1Bhatia M,Moochhala S.Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome[J].J Pathol,2004,202(2):145-156.
2Ronco C,Inguaggiato P,D扞ntini V,et al.The role of extracorporeal therapies in sepsis[J].J NEPHROL,2003,16(suppl.7):S34-S41.
3Marshall JC.Clinical trials of mediator-directed therapy in sepsis:what have we learned[J]? Intens Care Med,2000,26 (suppl 1):S75-83.
4Hotchkiss RS,Karl IE:The pathophysiology and treatment of sepsis[J].N Engl J Med,2003,348:138-150
6Tetta C,Ronco C,Brendolan A,et al.Present and future options in continuous renal replacement therapies of sepsis and MOF[J].Minerva Anestesiol,1999,65(6):419-426.
8Alexopoulos E,Vakianis P,Kokolina E,et al.Acute renal failure in a medical setting:changing patterns and prognostic factors[J].Renal Fail,1994,16(2):273-284.
9Liano F,Junco E,Pascual J,et al.The spectrum of acute renal failure in the ICU compared with that seen in other settings.The Madrid Acute Renal Failure Study Group[J].Kidney Int,1998,66:S16-24.
8Hou G,Liu T, Wang H, et al. Preparation of adsorbents for the removal of endotoxin[J].Artif Cells Blood Substit Immobil Bio- technol, 2005,33 (2) : 227-237.
9Axtelle T, Pribble J. IC14,a CD14 specific monoclonal antibody, is a potential treatment for patients with severe sepsis[J]. J Endo- toxin Res,2001,7(4) :310.
